Clomiphene, a selective oestrogen receptor modulator, has been utilised in managing male sub‐fertility since 1967. Numerous controlled and uncontrolled studies have been published regarding the efficacy of clomiphene citrate in male sub‐fertility cohorts.
T. Gundewar, M. Kuchakulla, R. Ramasamy
semanticscholar +1 more source
The impact of female obesity on the outcome of fertility treatment [PDF]
Peer reviewedPublisher ...
Abha Maheshwari +53 more
core +3 more sources
Objective: To compare the different polycystic ovarian syndrome (PCOS) phenotypes based on their clinical, metabolic, hormonal profile, and their differential response to clomiphene. Design: Prospective observational study. Setting: Infertility clinic, a
Garima Sachdeva +4 more
semanticscholar +1 more source
Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome [PDF]
Background The polycystic ovary syndrome is a common cause of infertility. Clomiphene and insulin sensitizers are used alone and in combination to induce ovulation, but it is unknown whether one approach is superior.
Barnhart, Huiman X. +14 more
core +2 more sources
Sperm chromatin dispersion test before sperm preparation is predictive of clinical pregnancy in cases of unexplained infertility treated with intrauterine insemination and induction with clomiphene citrate [PDF]
Background/aims: A large proportion of men with normal sperm results as analyzed using conventional techniques have fragmented DNA in their spermatozoa.
De Croo, Ilse +4 more
core +2 more sources
Clomiphene, a selective estrogen receptor modulator (SERM), has been used for the treatment of anovulation for more than 50 years. However, since (E)-clomiphene ((E)-Clom) and its metabolites are eliminated primarily via Cytochrome P450 (CYP) 2D6 and ...
Christina Kovar +11 more
doaj +1 more source
Metformin-letrozole in comparison with Metformin-clomiphene citrate in clomiphene-resistance PCOS patients undergoing IUI [PDF]
Background: Polycystic ovary syndrome (PCOS) is associated with approximately 75% of women who suffer from infertility due to anovulation. Additionally, around 20– 25% of anovulatory women with PCOS do not respond at all to clomiphene citrate and are ...
Mohammad Hossein Fallahzadeh +2 more
doaj
Clomiphene Citrate Treatment Cycle Outcomes of Polycystic Ovary Syndrome Patients Based on Basal High Sensitive C-Reactive Protein Levels: A Cross-Sectional Study [PDF]
Background Polycystic ovary syndrome (PCOS) is highly associated with an ovulatory infertility, features of the metabolic syndrome, including obesity, insulin resistance and dyslipidemia. Serum concentrations of high sensitive C-reactive protein (hs-CRP)
Serkan Kahyaoglu +7 more
doaj +1 more source
How do red and infrared low-level lasers affect folliculogenesis cycle in rat’s ovary tissue in comparison with clomiphene under in vivo condition [PDF]
Tabriz University of Medical Sciences, 5/89/137Peer reviewedPublisher ...
Alihemmati, Alireza +2 more
core +3 more sources
Correlation between obesity and successful ovulation induction with Clomiphene citrate
Ovulation induction with clomiphene citrate is a hormonal therapy for infertile women with impaired ovarian function caused by dysregulation of the hypothalamus and pituitary, affecting egg development and ovulation.
Rida Eka Setiani +2 more
doaj +1 more source

